Low back pain (LBP) is one of the highest prevalence problems of public health. LBP affects up to 85% people worldwide. Somebody will be affected at less in one point of his life. LBP represent an enormous economic burden on society; its total cost includes: Direct medical costs, work absenteeism, insurance, lost production and disability benefits. Current treatments range from bed rest, physiotherapy, oral analgesic, muscle relaxants, injection of corticosteroids, local anesthetic, surgery, cell based therapies aiming repair a herniated intervertebral disc and an emerging technique which use injectable hydrogels to restore disc height and function.
It was to show treatment methodology, its accuracy and health satisfaction in patients who developed LBP.
1,000 patients were subject to a treatment which consists of a combination of three therapies: Physic therapy, ozone and intravenous injections.
This method achieves decreases 4 points in a visual analogic scale (VAS) over 12 weeks without medication. It has a rate success of 73%. This methodology may be an applicable and useful tool to avoid the surgery in those patients who present an episode of LBP.
Randomized comparative trials are needed to further evaluate if our treatment is superior to lumbar disc surgery.